GeneDx Holdings

Historical price data

GeneDx is a mission-driven genomic diagnostics and data intelligence company focused on solving rare and complex genetic diseases. Its core achievement is building the industry's largest rare disease dataset, GeneDx Infinity™, which integrates genomic and phenotypic data to deliver a 17% higher diagnostic yield than standard testing. The company's strategy is to solidify its leadership in clinical diagnostics while monetizing its data asset through biopharma partnerships, creating a dual revenue engine. With dominant market penetration and a robust reimbursement footprint, GeneDx is positioned to define the standard of care in genomic medicine.

GeneDx Infinity™, a proprietary genomic data intelligence platform integrating one of the world's largest rare disease datasets (2.5M+ tests, ~1M exomes/genomes, 8M phenotypic points) with AI and clinical expertise to drive higher diagnostic yields.

GeneDx competes with large diagnostic labs (Quest, Labcorp) and specialized genomic firms, but its differentiation is its scale of rare disease data and clinical expertise. Its primary competitive advantage is the GeneDx Infinity™ dataset, which creates a virtuous cycle of higher diagnostic yield, more data, and improved interpretations that is difficult for rivals to replicate quickly.